SECsense Logo

Medifast, Inc. 8-K Report: Key Updates from February 18, 2025

$MED
Form 8-K
Filed on: 2025-02-18
Source
Medifast, Inc. 8-K Report: Key Updates from February 18, 2025

Here’s a summary of the key information extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: Medifast, Inc.
  • CIK (Central Index Key): 0000910329
  • Company Identifier: 001-31573
  • Tax Identification Number (EIN): 13-3714405
  • Address: 100 International Drive, Baltimore, MD 21202
  • Phone Number: 410-581-8042
  1. Security Information:
  • Type of Security: Common Stock
  • Par Value: $0.001 per share
  • Stock Exchange: NYSE (New York Stock Exchange)
  • Exchange Identifier: XNYS
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 18, 2025
  1. Context Information:
  • The report is associated with two contexts:
    • The first context covers the reporting period from February 18, 2025, to February 18, 2025, indicating a single-day report.
    • The second context references the entity's segment, confirming its listing on the NYSE.
  1. Regulatory Compliance:
  • The document adheres to SEC filing requirements, as indicated by the use of XBRL (eXtensible Business Reporting Language) for structured data representation.

Insights:

  • The filing date and the nature of the 8-K report suggest that Medifast, Inc. may be disclosing significant events or changes that occurred on that specific date.
  • The listing on the NYSE indicates the company is publicly traded, which allows for greater visibility and potential access to capital markets.
  • The document's structured format ensures compliance with SEC regulations, facilitating easier analysis and comparison within the financial community.

This information is crucial for investors, analysts, and stakeholders interested in Medifast, Inc.'s financial and operational status at the time of the filing.